Clinical trials – ALS diagnosis and stratification

Key Points

• ALS diagnosis significantly impacts treatment outcomes, affecting long-term survival rates and patient quality of life.
• Key biomarkers, such as neurofilament light chains, help accurately stratify ALS patients for tailored therapies.
• Observational analysis across multiple clinical trials reveals the crucial role of early diagnosis in improving interventions.
• Improved ALS stratification may enable personalized medicine approaches, enhancing overall patient care and outcomes.